Atosiban CAS 90779-69-4 is an inhibitor of the hormones oxytocin which is play an important role in halting premature labor (tocolytic). Experiment show that the pharmacodynamics of Atosiban is rapid , uterine contractions being significantly reduced within 10 minutes to achieve stable uterine quiescence. Atosiban CAS 90779-69-4 is more effective and safe than other medicine. Atosiban is commercial production and have certain specification.

Thera. Category: A Peptide Oxytocin Receptor Inhibitor

Cas No.: 90779-69-4

Synonym: 1-deamino-2d-tyr-(oet)-4-thr-8-orn-oxytocin;oxytocin,1-(3-mercaptopropanoicacid)-2-(o-ethyl-d-tyrosine)-4-l-threonine-8-l;rwj22164;ATOSIBAN ACETATE;1-(3-Mercaptopropionic acid)-2-(3-(p-ethoxyphenyl)-D-alanine)-4-L-thre onine-8-L-ornithineoxytocin;[Mpr-D-Tyr(OEt)-Ile-Thr-Asn-Cys]-Pro-Orn-Gly-NH2;(2S)-N-[(1S)-4-Amino-1-(carbamoylmethylcarbamoyl)butyl]-1-[(4S,7S,13S,16R)-13-[(2S)-butan-2-yl]-7-(carbamoylmethyl)-16-[(4-ethoxyphenyl)methyl]-10-(1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carbonyl]pyrrolidine-2-carboxamide;1-(3-Mercaptopropanoic acid)-2-(O-ethyl-D-tyrosine)-4-L-threonine-8-L-ornithineoxytocin

Molecular Formula: C45H71N11O14S2

Molecular Weight: 994.19

Assay: ≥99.%

Packing: Export worthy packing

lMaterial Safety Data Sheet: Available on request

Usage: Topical anti-inflammatory corticosteroidAtosiban is an oxytocin receptor blocking agent in the treatment of experimental endometriosis and was shown exhibit significant therapeutic efficiency